Sexual Impact of Treatment of Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia
Lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) and the treatment of these conditions are commonly associated with sexual dysfunction. The effects on sexual function of common medical and surgical therapies used in the treatment of LUTS/BPH are reviewed. Also discussed is the emerging use of phosphodiesterase inhibitors in the treatment of LUTS/BPH.
KeywordsLower urinary tract symptoms Benign prostatic hyperplasia Retrograde ejaculation Erectile dysfunction Alpha-1-adrenergic antagonist 5-alpha-reductase inhibitor Phosphodiesterase inhibitor Prostate photovaporization Holmium laser enucleation of the prostate Transurethral resection of the prostate Open prostatectomy
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 1.American Urological Association: AUA Guidelines on Management of Benign Prostatic Hyperplasia, 2003, revision 2006. Chapter 3. Available at http://www.auanet.org. Accessed February 2010.
- 9.Kirby RS, Roehrborn C, Boyle P, et al.: Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the Prospective European Doxazosin and Combination Therapy (PREDICT) trial. Urology 2003, 61:119–126.CrossRefPubMedGoogle Scholar
- 11.van Kerrebroeck P, Jardin A, Laval KU, van Cangh P: Efficacy and safety of a new prolonged release formulation of alfuzosin 10 mg once daily versus alfuzosin 2.5 mg thrice daily and placebo in patients with symptomatic benign prostatic hyperplasia. ALFORTI Study Group. Eur Urol 2000, 37:306–313.CrossRefPubMedGoogle Scholar
- 20.Marberger MJ: Long-term effects of finasteride in patients with benign prostatic hyperplasia: a double-blind, placebo-controlled, multicenter study. PROWESS Study Group. Urology 1998, 51:677–686.Google Scholar
- 24.• Roehrborn CG, McVary KT, Elion-Mboussa A, Viktrup L: Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study. J Urol 2008, 180:1228–1234. This excellent follow-up study to McVary et al. 2007 redemonstrates the efficacy of PDE5Is over placebo and provides useful clinical information regarding appropriate dosing.CrossRefPubMedGoogle Scholar
- 26.Liguori G, Trombetta C, De Giorgi G, et al.: Efficacy and safety of combined oral therapy with tadalafil and alfuzosin: an integrated approach to the management of patients with lower urinary tract symptoms and erectile dysfunction. Preliminary report. J Sex Med 2009, 6:544–552.CrossRefPubMedGoogle Scholar
- 32.• Jaidane M, Arfa NB, Hmida W, et al.: Effect of transurethral resection of the prostate on erectile function: a prospective comparative study. Int J Impot Res 2010, 22:146–151. This unusual and useful study used TURBT as a sham study for comparison with TURP and its effects on erectile function.CrossRefPubMedGoogle Scholar